Polymerase chain reaction single-strand conformational polymorphism analysis of antigen receptor rearrangements in monitoring therapeutic effect in childhood ALL

被引:1
作者
Thunberg, U [1 ]
Sallstrom, J
Frost, BM
Lonnerholm, G
Sundstrom, C
机构
[1] Univ Uppsala Hosp, Dept Pathol, S-75185 Uppsala, Sweden
[2] Univ Uppsala Hosp, Dept Pediat, S-75185 Uppsala, Sweden
关键词
immunoglobulin; rearrangement; PCR-SSCP; leukemia;
D O I
10.1097/00019606-199806000-00004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The rearrangement of the immunoglobulin heavy chain (IgH) genes can be used as a marker of cell lineage and clonality. The polymerase chain reaction (PCR) technique using consensus primers for the IgH gene was used for remission and minimal residual disease (MRD) analysis in the follow-up of childhood acute lymphoblastic leukemia (ALL) of B-cell lineage. Single-strand conformational polymorphism (SSCP) was used to distinguish the specific clonal amplicons from the background. The Authors found that, in a series of 22 patients followed-up for 5.3 to 11.1 years, the PCR-SSCP technique could detect at least one rearrangement at initial diagnosis in 21 (95%). All patients who remained in continuous complete remission were PCR-SSCP negative at remission controls. Ten of the 22 patients had one or more bone marrow relapses. The PCR-SSCP method demonstrated MRD in three of them. In 6 of the 7 (86%) of patients with disease recurrence from whom samples were taken within 6 months before a clinically overt relapse, PCR-SSCP became positive. The Authors conclude that PCR-SSCP of a rearrangement marker might have a role as a convenient technique for monitoring emerging relapse. It may also detect unrelated clones or ongoing secondary recombination events during progression. However, PCR-SSCP is not sensitive enough to detect MRD in all patients in whom disease will later recur.
引用
收藏
页码:146 / 151
页数:6
相关论文
共 45 条
[1]   DIAGNOSTIC SINGLE-STRAND CONFORMATIONAL POLYMORPHISM, (SSCP) - A SIMPLIFIED NONRADIOISOTOPIC METHOD AS APPLIED TO A TAY-SACHS-B1 VARIANT [J].
AINSWORTH, PJ ;
SURH, LC ;
COULTERMACKIE, MB .
NUCLEIC ACIDS RESEARCH, 1991, 19 (02) :405-406
[2]   REGULATION OF GENOME REARRANGEMENT EVENTS DURING LYMPHOCYTE DIFFERENTIATION [J].
ALT, FW ;
BLACKWELL, TK ;
DEPINHO, RA ;
RETH, MG ;
YANCOPOULOS, GD .
IMMUNOLOGICAL REVIEWS, 1986, 89 :5-30
[3]   IMMUNOGLOBULIN-GENE REARRANGEMENTS AS UNIQUE CLONAL MARKERS IN HUMAN LYMPHOID NEOPLASMS [J].
ARNOLD, A ;
COSSMAN, J ;
BAKHSHI, A ;
JAFFE, ES ;
WALDMANN, TA ;
KORSMEYER, SJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (26) :1593-1599
[4]  
BILLADEAU D, 1991, BLOOD, V78, P3021
[5]   OUTCOME PREDICTION IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA BY MOLECULAR QUANTIFICATION OF RESIDUAL DISEASE AT THE END OF INDUCTION [J].
BRISCO, MJ ;
CONDON, J ;
HUGHES, E ;
NEOH, SH ;
SYKES, PJ ;
SESHADRI, R ;
TOOGOOD, I ;
WATERS, K ;
TAURO, G ;
EKERT, H ;
MORLEY, AA .
LANCET, 1994, 343 (8891) :196-200
[6]   Relationship between minimal residual disease and outcome in adult acute lymphoblastic leukemia [J].
Brisco, MJ ;
Hughes, E ;
Neoh, SH ;
Sykes, PJ ;
Bradstock, K ;
Enno, A ;
Szer, J ;
McCaul, K ;
Morley, AA .
BLOOD, 1996, 87 (12) :5251-5256
[7]  
CAMPANA D, 1991, BONE MARROW TRANSPL, V8, P429
[8]   DETECTION OF MINIMAL RESIDUAL DISEASE IN ACUTE-LEUKEMIA - METHODOLOGIC ADVANCES AND CLINICAL-SIGNIFICANCE [J].
CAMPANA, D ;
PUI, CH .
BLOOD, 1995, 85 (06) :1416-1434
[9]  
CARLO SC, 1995, LEUK LYMPHOMA, V1, P75
[10]   The use of IgH fingerprinting and ASO-dependent: PCR for the investigation of residual disease (MRD) in ALL [J].
Chim, JCS ;
Coyle, LA ;
Yaxley, JC ;
ColeSinclair, MF ;
Cannell, PK ;
Hoffbrand, VA ;
Foroni, L .
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 92 (01) :104-115